financetom
Business
financetom
/
Business
/
Microsoft's hiring of former Inflection AI staff prompts UK probe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Microsoft's hiring of former Inflection AI staff prompts UK probe
Jul 16, 2024 6:26 AM

By Yadarisa Shabong and Martin Coulter

July 16 (Reuters) - Britain's competition regulator has

started a formal investigation into Microsoft's ( MSFT ) hiring

of some former staff of Inflection AI and its partnership with

the startup, it said on Tuesday.

Over the past 18 months, regulators around the world have

increasingly focused on potentially anti-competitive behaviour

in the AI industry, with Microsoft's ( MSFT ) various deals with smaller

startups facing mounting scrutiny.

In March, the tech giant hired Mustafa Suleyman, co-founder

of Google DeepMind, as head of its newly-created AI

unit. It also hired a number of employees from Inflection, which

he set up in 2022.

Reuters reported that Microsoft ( MSFT ) had agreed to pay Inflection

about $650 million as part of the deal. This allowed it access

to Inflection's AI models, and enabled the startup to reimburse

its investors, who include former Google CEO Eric Schmidt and

Bill Gates.

Responding to the UK Competition and Markets Authority's

(CMA) investigation, a Microsoft ( MSFT ) spokesperson said in an emailed

statement to Reuters: "We are confident that the hiring of

talent promotes competition and should  not be treated as a

merger.

"We will provide the UK Competition and Markets Authority

with the information it needs to complete its enquiries

expeditiously."

The CMA has until Sept. 11 to decide whether or not it would

refer the deal for a more in-depth investigation.

Microsoft ( MSFT ) was already facing questions over its partnerships

with leading AI startups such as OpenAI and France's Mistral AI.

Last week, it gave up its board observer seat at OpenAI in a

move aimed at easing U.S. and British antitrust regulators'

concerns about the extent of its control over the AI startup.

The CMA has also sought views on partnerships between Amazon ( AMZN )

and Anthropic.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Selina Hospitality Gets Delinquency Notification From Nasdaq
Selina Hospitality Gets Delinquency Notification From Nasdaq
May 24, 2024
04:43 AM EDT, 05/24/2024 (MT Newswires) -- Selina Hospitality ( SLNA ) said Thursday it received a notice from the Nasdaq Stock Market informing the company of its delinquency in filing its Form 20-F for the year ended Dec. 31. The notice specifies the delay as an added basis for potentially delisting the company's securities. Selina is non-compliant with the...
Bloom Energy Prices $350 Million Upsized Private Placement of Green Convertible Senior Notes
Bloom Energy Prices $350 Million Upsized Private Placement of Green Convertible Senior Notes
May 24, 2024
04:30 AM EDT, 05/24/2024 (MT Newswires) -- Bloom Energy ( BE ) said Friday it priced a $350 million private offering of 3% green convertible senior notes due 2029 to qualified institutional buyers. Initial purchasers have been granted a 13-day option to purchase up to an additional $52.5 million worth of notes. The initial conversion rate is 47.9795 shares of...
Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment
Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment
May 24, 2024
04:55 AM EDT, 05/24/2024 (MT Newswires) -- Evaxion Biotech ( EVAX ) said late Thursday it plans to present positive immune data from a phase 2 study assessing its personalized cancer vaccine EVX-01 combined with anti-PD1 therapy in patients with advanced melanoma. The company will present the data at an oncology conference in Chicago, Illinois, from May 31 to June...
Guardant Health Says Colorectal Cancer Detection Test Receives FDA Panel Recommendation
Guardant Health Says Colorectal Cancer Detection Test Receives FDA Panel Recommendation
May 24, 2024
04:57 AM EDT, 05/24/2024 (MT Newswires) -- Guardant Health ( GH ) said late Thursday a panel of the US Food and Drug Administration's Medical Devices Advisory Committee has recommended approval of the company's Shield blood test for colorectal cancer screening in adults who are at least 45 years old and at average risk for the disease. Panel members voted...
Copyright 2023-2026 - www.financetom.com All Rights Reserved